Table 3.
Controls (n = 27) | Infected cases (n = 92) | p | ||
---|---|---|---|---|
CR1-4646 A > G | A/A | 18 (66.7%) | 76 (82.6%) | |
N1540S | A/G | 7 (25.9%) | 16 (17.4%) | |
G/G | 2 (7.4%) | 0 (0%) | ||
- | ||||
CR1-4708 G > A | G/G | 26 (96.3%) | 72 (78.3%) | |
V1561M | G/A | 1 (3.7%) | 20 (21.7%) | |
Kna/b | A/A | 0 (0%) | 0 (0%) | |
0.0415 | ||||
CR1-4795 A > G | A/A | 25 (92.6%) | 83 (90.2%) | |
K1590E | A/G | 2 (7.4%) | 8 (8.7%) | |
McCa/b | G/G | 0 (0%) | 1 (1.1%) | |
- | ||||
CR1-4828 A > G | A/A | 20 (74.1%) | 70 (76.1%) | |
R1601G | A/G | 7 (25.9%) | 20 (21.7%) | |
Sl1/Sl2 | G/G | 0 (0%) | 2 (2.2%) | |
- | ||||
CR1-4855 T > A | T/T | 27 (100%) | 92 (100%) | |
S1610T | T/A | 0 (0%) | 0 (0%) | |
Sl4/Sl5 | A/A | 0 (0%) | 0 (0%) | |
- | ||||
CR1-4870 A > G | A/A | 10 (37.0%) | 29 (31.5%) | |
I1615V | A/G | 11 (40.7%) | 41 (44.5%) | |
KAM−/KAM+ | G/G | 6 (22.3%) | 22 (24.0%) | |
- |